speb/financial-data huggingface dataset:
IRIX income_statement (quarterly, 2025-12-31) — EBITDA: 407000.00
IRIX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -65000.00
IRIX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -1000.00
IRIX cash_flow (annual, 2025-12-31) — End Cash Position: 6028000.00
IRIX cash_flow (quarterly, 2025-12-31) — End Cash Position: 6028000.00
IRIX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 5964000.00
IRIX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -27000.00
IRIX balance_sheet (annual, 2025-12-31) — Finished Goods: 3729000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 3729000.00
IRIX cash_flow (annual, 2025-12-31) — Free Cash Flow: -2258000.00
IRIX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 483000.00
IRIX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -14000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -14000.00
IRIX income_statement (annual, 2025-12-31) — General And Administrative Expense: 7734000.00
IRIX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1792000.00
IRIX balance_sheet (annual, 2025-12-31) — Goodwill: 965000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Goodwill: 965000.00
IRIX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1949000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1949000.00
IRIX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 7725000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 7725000.00
IRIX balance_sheet (annual, 2025-12-31) — Gross PPE: 15009000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 15009000.00
IRIX income_statement (annual, 2025-12-31) — Gross Profit: 19227000.00
IRIX income_statement (quarterly, 2025-12-31) — Gross Profit: 5477000.00
IRIX balance_sheet (annual, 2025-12-31) — Inventory: 7877000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Inventory: 7877000.00
IRIX balance_sheet (annual, 2025-12-31) — Invested Capital: 2657000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2657000.00
IRIX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -143000.00
IRIX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -106000.00
IRIX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 10000000.00
IRIX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 4000000.00
IRIX balance_sheet (annual, 2025-12-31) — Leases: 2494000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Leases: 2494000.00
IRIX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 98000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 98000.00
IRIX balance_sheet (annual, 2025-12-31) — Long Term Debt: 3735000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 3735000.00
IRIX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3833000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 3833000.00
IRIX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -3961000.00
IRIX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
IRIX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 4000000.00
IRIX income_statement (annual, 2025-12-31) — Net Income: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Net Income: -184000.00
IRIX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -184000.00
IRIX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -184000.00
IRIX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -184000.00
IRIX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -184000.00
IRIX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -4437000.00
IRIX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -184000.00
IRIX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -184000.00
IRIX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -3961000.00
IRIX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -4000000.00
IRIX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -3961000.00
IRIX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -4000000.00
IRIX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -75000.00
IRIX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -27000.00
IRIX balance_sheet (annual, 2025-12-31) — Net PPE: 826000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Net PPE: 826000.00
IRIX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -143000.00
IRIX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -106000.00
IRIX cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 6000000.00
IRIX cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 0.00
IRIX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2973000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2973000.00
IRIX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 6801000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 6801000.00
IRIX balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 6801000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 6801000.00
IRIX income_statement (annual, 2025-12-31) — Normalized EBITDA: -1024000.00
IRIX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 407000.00
IRIX income_statement (annual, 2025-12-31) — Normalized Income: -4437000.00
IRIX income_statement (quarterly, 2025-12-31) — Normalized Income: -184000.00
IRIX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -2115000.00
IRIX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 589000.00
IRIX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1335000.00
IRIX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 0.00
IRIX income_statement (annual, 2025-12-31) — Operating Income: -2571000.00
IRIX income_statement (quarterly, 2025-12-31) — Operating Income: -15000.00
IRIX income_statement (annual, 2025-12-31) — Operating Revenue: 52675000.00
IRIX income_statement (quarterly, 2025-12-31) — Operating Revenue: 21273000.00
IRIX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 17306521.00
IRIX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 17306521.00
IRIX balance_sheet (annual, 2025-12-31) — Other Current Assets: 1802000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1802000.00
IRIX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -14000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -14000.00
IRIX income_statement (annual, 2025-12-31) — Other Gand A: 7734000.00
IRIX income_statement (quarterly, 2025-12-31) — Other Gand A: 1792000.00
IRIX income_statement (annual, 2025-12-31) — Other Income Expense: -1809000.00
IRIX income_statement (quarterly, 2025-12-31) — Other Income Expense: -149000.00
IRIX balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 984000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 984000.00
IRIX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 227000.00
IRIX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 30000.00
IRIX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 1124000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 1124000.00
IRIX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 387000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 387000.00
IRIX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1809000.00
IRIX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -149000.00
IRIX balance_sheet (annual, 2025-12-31) — Other Payable: 137000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Payable: 137000.00
IRIX balance_sheet (annual, 2025-12-31) — Other Properties: 12515000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Other Properties: 12515000.00
IRIX balance_sheet (annual, 2025-12-31) — Payables: 5670000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Payables: 5670000.00
IRIX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6492000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6492000.00
IRIX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2340000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2340000.00
IRIX balance_sheet (annual, 2025-12-31) — Preferred Stock: 6000000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 6000000.00
IRIX balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 6000000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 6000000.00
IRIX cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 6000000.00
IRIX cash_flow (quarterly, 2025-12-31) — Preferred Stock Issuance: 0.00
IRIX income_statement (annual, 2025-12-31) — Pretax Income: -4380000.00
IRIX income_statement (quarterly, 2025-12-31) — Pretax Income: -164000.00
IRIX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
IRIX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
IRIX balance_sheet (annual, 2025-12-31) — Properties: 0.00
IRIX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IRIX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -143000.00
IRIX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -106000.00
IRIX balance_sheet (annual, 2025-12-31) — Raw Materials: 4148000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4148000.00
IRIX balance_sheet (annual, 2025-12-31) — Receivables: 9545000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Receivables: 9545000.00
IRIX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 33448000.00
IRIX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 9247000.00
IRIX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1547000.00
IRIX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 422000.00
IRIX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -3961000.00
IRIX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
IRIX income_statement (annual, 2025-12-31) — Research And Development: 3668000.00
IRIX income_statement (quarterly, 2025-12-31) — Research And Development: 949000.00
IRIX balance_sheet (annual, 2025-12-31) — Retained Earnings: -92446000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -92446000.00
IRIX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 10396000.00
IRIX income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2751000.00
IRIX income_statement (annual, 2025-12-31) — Selling General And Administration: 18130000.00
IRIX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 4543000.00
IRIX balance_sheet (annual, 2025-12-31) — Share Issued: 17306521.00
IRIX balance_sheet (quarterly, 2025-12-31) — Share Issued: 17306521.00
IRIX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 775000.00
IRIX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 213000.00
IRIX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4922000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4922000.00
IRIX balance_sheet (annual, 2025-12-31) — Tangible Book Value: -3027000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -3027000.00
IRIX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (annual, 2025-12-31) — Tax Provision: 57000.00
IRIX income_statement (quarterly, 2025-12-31) — Tax Provision: 20000.00
IRIX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.40
IRIX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.40
IRIX balance_sheet (annual, 2025-12-31) — Total Assets: 29151000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Assets: 29151000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Capitalization: 8657000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 8657000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Debt: 4532000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Debt: 4532000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4922000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4922000.00
IRIX income_statement (annual, 2025-12-31) — Total Expenses: 55246000.00
IRIX income_statement (quarterly, 2025-12-31) — Total Expenses: 14739000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 24229000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 24229000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3899000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3899000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 11021000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 11021000.00
IRIX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -2571000.00
IRIX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -15000.00
IRIX balance_sheet (annual, 2025-12-31) — Total Tax Payable: 31000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 31000.00
IRIX balance_sheet (annual, 2025-12-31) — Work In Process: 0.00
IRIX balance_sheet (quarterly, 2025-12-31) — Work In Process: 0.00
IRIX balance_sheet (annual, 2025-12-31) — Working Capital: 12044000.00
IRIX balance_sheet (quarterly, 2025-12-31) — Working Capital: 12044000.00
IRIX income_statement (quarterly, 2026-03-31) — +Operating Expense: 5065000.00
IRIX income_statement (quarterly, 2026-03-31) — +Total Revenue: 11799000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 5753000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 6844000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 91538000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -112000.00
IRIX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 17311000.00
IRIX income_statement (quarterly, 2026-03-31) — Basic EPS: -0.03
IRIX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 6028000.00
IRIX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -101000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 511000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 6174000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4595000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4595000.00
IRIX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -1000.00
IRIX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -101000.00
IRIX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -1335000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 368000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -538000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -1448000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -62000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -112000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -499000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Payable: 552000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 14000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -446000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Receivables: 1129000.00
IRIX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1424000.00
IRIX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 769000.00
IRIX cash_flow (quarterly, 2026-03-31) — Changes In Cash: -1437000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Common Stock: 174000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -1268000.00
IRIX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 7058000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 692000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Assets: 24584000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 424000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 424000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2040000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2040000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 12828000.00
IRIX cash_flow (quarterly, 2026-03-31) — Depreciation: 372000.00
IRIX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 372000.00
IRIX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 372000.00
IRIX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 17311000.00
IRIX income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.03
IRIX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -524000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 1572000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 301000.00
IRIX income_statement (quarterly, 2026-03-31) — EBIT: -324000.00
IRIX income_statement (quarterly, 2026-03-31) — EBITDA: 48000.00
IRIX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 4000.00
IRIX cash_flow (quarterly, 2026-03-31) — End Cash Position: 4595000.00
IRIX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -1000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 3371000.00
IRIX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -1436000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -10000.00
IRIX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1623000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Goodwill: 965000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1869000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 6956000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 635000.00
IRIX income_statement (quarterly, 2026-03-31) — Gross Profit: 4741000.00
IRIX cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
IRIX balance_sheet (quarterly, 2026-03-31) — Inventory: 9325000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2497000.00
IRIX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -101000.00
IRIX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
IRIX cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
IRIX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 87000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 3765000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 3852000.00
IRIX cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
IRIX cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
IRIX income_statement (quarterly, 2026-03-31) — Net Income: -524000.00
IRIX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -524000.00
IRIX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -524000.00
IRIX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -524000.00
IRIX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -524000.00
IRIX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -524000.00
IRIX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -524000.00
IRIX cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
IRIX cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
IRIX cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -1000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Net PPE: 635000.00
IRIX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -101000.00
IRIX cash_flow (quarterly, 2026-03-31) — Net Preferred Stock Issuance: 0.00
IRIX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2863000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 6422000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 6422000.00
IRIX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 48000.00
IRIX income_statement (quarterly, 2026-03-31) — Normalized Income: -524000.00
IRIX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -1335000.00
IRIX income_statement (quarterly, 2026-03-31) — Operating Income: -324000.00
IRIX income_statement (quarterly, 2026-03-31) — Operating Revenue: 11799000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 17395350.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2248000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1900000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -10000.00
IRIX income_statement (quarterly, 2026-03-31) — Other Gand A: 1623000.00
IRIX income_statement (quarterly, 2026-03-31) — Other Income Expense: -142000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 904000.00
IRIX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 30000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1186000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 440000.00
IRIX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -142000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Other Properties: 635000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Payables: 6054000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6746000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1718000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 6000000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 6000000.00
IRIX cash_flow (quarterly, 2026-03-31) — Preferred Stock Issuance: 0.00
IRIX income_statement (quarterly, 2026-03-31) — Pretax Income: -466000.00
IRIX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -101000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Raw Materials: 5954000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Receivables: 8416000.00
IRIX income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 7058000.00
IRIX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 372000.00
IRIX cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
IRIX income_statement (quarterly, 2026-03-31) — Research And Development: 905000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -92970000.00
IRIX income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 2537000.00
IRIX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 4160000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Share Issued: 17395350.00
IRIX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 211000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4732000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -3137000.00
IRIX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IRIX income_statement (quarterly, 2026-03-31) — Tax Provision: 58000.00
IRIX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
IRIX balance_sheet (quarterly, 2026-03-31) — Total Assets: 28274000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8497000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Total Debt: 4276000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4732000.00
IRIX income_statement (quarterly, 2026-03-31) — Total Expenses: 12123000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 23542000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3690000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 10714000.00
IRIX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -324000.00
IRIX balance_sheet (quarterly, 2026-03-31) — Work In Process: 0.00
IRIX balance_sheet (quarterly, 2026-03-31) — Working Capital: 11756000.00
IRM cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
IRM cash_flow (annual, 2021-12-31) — Cash From Discontinued Financing Activities: 0.00
IRM cash_flow (annual, 2021-12-31) — Cash From Discontinued Investing Activities: 0.00
IRM cash_flow (annual, 2021-12-31) — Cash From Discontinued Operating Activities: 0.00
IRM income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
IRM income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
IRM cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -192269000.00
IRM balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 72411000.00
IRM balance_sheet (annual, 2021-12-31) — Prepaid Assets: 224020000.00
IRM income_statement (annual, 2021-12-31) — Rent Expense Supplemental: 795802000.00
IRM cash_flow (annual, 2021-12-31) — Sale Of Business: 213878000.00
IRM cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 4972214000.00
IRM cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -5164483000.00
IRM income_statement (annual, 2022-12-31) — +Operating Expense: 1868172000.00
IRM income_statement (annual, 2022-12-31) — +Total Revenue: 5103574000.00
IRM balance_sheet (annual, 2022-12-31) — Accounts Payable: 469198000.00
IRM balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1174915000.00
IRM balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -3910321000.00
IRM balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 4468035000.00
IRM balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -54143000.00
IRM cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 266655000.00
IRM cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 266655000.00
IRM cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
IRM income_statement (annual, 2022-12-31) — Basic Average Shares: 290812000.00
IRM income_statement (annual, 2022-12-31) — Basic EPS: 1.92
IRM cash_flow (annual, 2022-12-31) — Beginning Cash Position: 255828000.00
IRM balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 3336778000.00
IRM cash_flow (annual, 2022-12-31) — Capital Expenditure: -883583000.00
IRM cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -875378000.00
IRM balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 2717905000.00
IRM balance_sheet (annual, 2022-12-31) — Capital Stock: 2908000.00
IRM balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 141797000.00
IRM balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 141797000.00
IRM cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -724388000.00
IRM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 639207000.00
IRM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1660423000.00
IRM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 927695000.00
IRM cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -224641000.00
IRM cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -27795000.00
IRM cash_flow (annual, 2022-12-31) — Change In Working Capital: -252436000.00
IRM cash_flow (annual, 2022-12-31) — Changes In Cash: -93521000.00
IRM balance_sheet (annual, 2022-12-31) — Common Stock: 2908000.00
IRM cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -724388000.00
IRM balance_sheet (annual, 2022-12-31) — Common Stock Equity: 636668000.00
IRM balance_sheet (annual, 2022-12-31) — Construction In Progress: 936269000.00
IRM income_statement (annual, 2022-12-31) — Cost Of Revenue: 2189120000.00
IRM balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 541713000.00
IRM balance_sheet (annual, 2022-12-31) — Current Assets: 1547145000.00
IRM balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 288738000.00
IRM balance_sheet (annual, 2022-12-31) — Current Debt: 87546000.00
IRM balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 376284000.00
IRM balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 336097000.00
IRM balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 328910000.00
IRM balance_sheet (annual, 2022-12-31) — Current Liabilities: 1917564000.00
IRM cash_flow (annual, 2022-12-31) — Deferred Income Tax: -55920000.00
IRM cash_flow (annual, 2022-12-31) — Deferred Tax: -55920000.00
IRM cash_flow (annual, 2022-12-31) — Depreciation: 478984000.00
IRM cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 745639000.00
IRM income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 727595000.00
IRM cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 745639000.00
IRM income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 727595000.00
IRM income_statement (annual, 2022-12-31) — Diluted Average Shares: 292444177.00
IRM income_statement (annual, 2022-12-31) — Diluted EPS: 1.90
IRM income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 556981000.00
IRM balance_sheet (annual, 2022-12-31) — Dividends Payable: 194272000.00
IRM income_statement (annual, 2022-12-31) — EBIT: 1127928000.00
IRM income_statement (annual, 2022-12-31) — EBITDA: 1873567000.00
IRM cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -20510000.00
IRM cash_flow (annual, 2022-12-31) — End Cash Position: 141797000.00
IRM cash_flow (annual, 2022-12-31) — Financing Cash Flow: 639207000.00
IRM cash_flow (annual, 2022-12-31) — Free Cash Flow: 44112000.00
IRM cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 70004000.00
IRM cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -93268000.00
IRM income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 93268000.00
IRM income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 61684000.00
IRM balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -442003000.00
IRM income_statement (annual, 2022-12-31) — General And Administrative Expense: 839844000.00
IRM balance_sheet (annual, 2022-12-31) — Goodwill: 4882734000.00
IRM balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 6305879000.00
IRM balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 1229058000.00
IRM balance_sheet (annual, 2022-12-31) — Gross PPE: 11609469000.00
IRM income_statement (annual, 2022-12-31) — Gross Profit: 2914454000.00
IRM income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
IRM cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 99631000.00
IRM income_statement (annual, 2022-12-31) — Interest Expense: 496290000.00
IRM income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 496290000.00
IRM income_statement (annual, 2022-12-31) — Interest Income: 8276000.00
IRM income_statement (annual, 2022-12-31) — Interest Income Non Operating: 8276000.00
IRM cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 482673000.00
IRM balance_sheet (annual, 2022-12-31) — Interest Payable: 128272000.00
IRM balance_sheet (annual, 2022-12-31) — Invested Capital: 11205663000.00
IRM cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1660423000.00
IRM cash_flow (annual, 2022-12-31) — Issuance Of Debt: 12949766000.00
IRM balance_sheet (annual, 2022-12-31) — Land And Improvements: 486715000.00
IRM balance_sheet (annual, 2022-12-31) — Leases: 1079419000.00
IRM balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2429167000.00
IRM balance_sheet (annual, 2022-12-31) — Long Term Debt: 10481449000.00
IRM balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 12910616000.00
IRM cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 12949766000.00
IRM cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -11596405000.00
IRM balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1128530000.00
IRM balance_sheet (annual, 2022-12-31) — Minority Interest: 95285000.00
IRM income_statement (annual, 2022-12-31) — Minority Interests: -5168000.00
IRM cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -876923000.00
IRM balance_sheet (annual, 2022-12-31) — Net Debt: 10427198000.00
IRM cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -19853000.00
IRM income_statement (annual, 2022-12-31) — Net Income: 556981000.00
IRM income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 556981000.00
IRM income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 562149000.00
IRM income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 556981000.00
IRM income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 556981000.00
IRM cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 562149000.00
IRM income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 562149000.00
IRM cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -8205000.00
IRM income_statement (annual, 2022-12-31) — Net Interest Income: -488014000.00
IRM cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 1353361000.00
IRM cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 1353361000.00
IRM income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -488014000.00
IRM cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 15083000.00
IRM cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -70336000.00
IRM balance_sheet (annual, 2022-12-31) — Net PPE: 7699148000.00
IRM cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 170419000.00
IRM cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 1356314000.00
IRM balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -5669211000.00
IRM balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 263005000.00
IRM balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 263005000.00
IRM income_statement (annual, 2022-12-31) — Normalized EBITDA: 1808965000.00
IRM income_statement (annual, 2022-12-31) — Normalized Income: 499485220.00
IRM cash_flow (annual, 2022-12-31) — Operating Cash Flow: 927695000.00
IRM cash_flow (annual, 2022-12-31) — Operating Gains Losses: -43117000.00
IRM income_statement (annual, 2022-12-31) — Operating Income: 1046282000.00
IRM income_statement (annual, 2022-12-31) — Operating Revenue: 5103574000.00
IRM balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 290830296.00
IRM balance_sheet (annual, 2022-12-31) — Other Current Assets: 230433000.00
IRM balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 87546000.00
IRM balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -442003000.00
IRM income_statement (annual, 2022-12-31) — Other Gand A: 839844000.00
IRM income_statement (annual, 2022-12-31) — Other Income Expense: 73370000.00
IRM balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 1423145000.00
IRM cash_flow (annual, 2022-12-31) — Other Non Cash Items: -85481000.00
IRM balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 588342000.00
IRM balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 317376000.00
IRM income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 8768000.00
IRM balance_sheet (annual, 2022-12-31) — Other Properties: 4641758000.00
IRM income_statement (annual, 2022-12-31) — Other Special Charges: 671000.00
IRM balance_sheet (annual, 2022-12-31) — Payables: 663470000.00
IRM balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1205183000.00
IRM balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 95160000.00
IRM balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
IRM income_statement (annual, 2022-12-31) — Pretax Income: 631638000.00
IRM cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: -4849000.00
IRM balance_sheet (annual, 2022-12-31) — Properties: 0.00
IRM cash_flow (annual, 2022-12-31) — Purchase Of Business: -876923000.00
IRM cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -8205000.00
IRM balance_sheet (annual, 2022-12-31) — Receivables: 1174915000.00
IRM income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2171076000.00
IRM income_statement (annual, 2022-12-31) — Reconciled Depreciation: 745639000.00
IRM cash_flow (annual, 2022-12-31) — Repayment Of Debt: -11596405000.00
IRM income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 89679000.00
IRM balance_sheet (annual, 2022-12-31) — Retained Earnings: -3392272000.00
IRM cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
IRM cash_flow (annual, 2022-12-31) — Sale Of PPE: 170419000.00
IRM income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 300733000.00
IRM income_statement (annual, 2022-12-31) — Selling General And Administration: 1140577000.00
IRM balance_sheet (annual, 2022-12-31) — Share Issued: 290830296.00
IRM cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 12949766000.00
IRM cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -11593452000.00
IRM income_statement (annual, 2022-12-31) — Special Income Charges: 2918000.00
IRM cash_flow (annual, 2022-12-31) — Stock Based Compensation: 56861000.00
IRM balance_sheet (annual, 2022-12-31) — Stockholders Equity: 636668000.00
IRM balance_sheet (annual, 2022-12-31) — Tangible Book Value: -5669211000.00
IRM income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 7106220.00
IRM income_statement (annual, 2022-12-31) — Tax Provision: 69489000.00
IRM income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.11
IRM balance_sheet (annual, 2022-12-31) — Total Assets: 16140514000.00
IRM balance_sheet (annual, 2022-12-31) — Total Capitalization: 11118117000.00
IRM balance_sheet (annual, 2022-12-31) — Total Debt: 13286900000.00
IRM balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 731953000.00
IRM income_statement (annual, 2022-12-31) — Total Expenses: 4057292000.00
IRM balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 15408561000.00
IRM balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 14593369000.00
IRM balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 13490997000.00
IRM income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1049871000.00
IRM income_statement (annual, 2022-12-31) — Total Unusual Items: 64602000.00
IRM income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 64602000.00
IRM balance_sheet (annual, 2022-12-31) — Working Capital: -370419000.00
IRM income_statement (annual, 2023-12-31) — +Operating Expense: 2012446000.00
IRM income_statement (annual, 2023-12-31) — +Total Revenue: 5480289000.00
IRM balance_sheet (annual, 2023-12-31) — Accounts Payable: 539594000.00
IRM balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1259826000.00
IRM balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4059120000.00
IRM balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4533691000.00
IRM balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -74762000.00
IRM cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 267168000.00
IRM cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 267168000.00
IRM income_statement (annual, 2023-12-31) — Basic Average Shares: 293365000.00
IRM income_statement (annual, 2023-12-31) — Basic EPS: 0.63
IRM cash_flow (annual, 2023-12-31) — Beginning Cash Position: 141797000.00
IRM balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 3819241000.00
IRM cash_flow (annual, 2023-12-31) — Capital Expenditure: -1345097000.00
IRM cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -1339223000.00
IRM balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2854189000.00
IRM balance_sheet (annual, 2023-12-31) — Capital Stock: 2921000.00
IRM balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 222789000.00
IRM balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 222789000.00
IRM cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -737650000.00
IRM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 425666000.00
IRM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1444356000.00
IRM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1113567000.00
IRM cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -70287000.00
IRM cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 29693000.00
IRM cash_flow (annual, 2023-12-31) — Change In Working Capital: -40594000.00
IRM cash_flow (annual, 2023-12-31) — Changes In Cash: 94877000.00
IRM balance_sheet (annual, 2023-12-31) — Common Stock: 2921000.00
IRM cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -737650000.00
IRM balance_sheet (annual, 2023-12-31) — Common Stock Equity: 211648000.00
IRM balance_sheet (annual, 2023-12-31) — Construction In Progress: 1622780000.00
IRM income_statement (annual, 2023-12-31) — Cost Of Revenue: 2357800000.00
IRM balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 341807000.00
IRM balance_sheet (annual, 2023-12-31) — Current Assets: 1735545000.00
IRM balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 291795000.00
IRM balance_sheet (annual, 2023-12-31) — Current Debt: 120670000.00
IRM balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 412465000.00
IRM balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 496938000.00
IRM balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 325665000.00
IRM balance_sheet (annual, 2023-12-31) — Current Liabilities: 2236188000.00
IRM cash_flow (annual, 2023-12-31) — Deferred Income Tax: -35264000.00
IRM cash_flow (annual, 2023-12-31) — Deferred Tax: -35264000.00
IRM cash_flow (annual, 2023-12-31) — Depreciation: 525850000.00
IRM cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 793018000.00
IRM income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 776159000.00
IRM cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 793018000.00
IRM income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 776159000.00
IRM income_statement (annual, 2023-12-31) — Diluted Average Shares: 293965000.00
IRM income_statement (annual, 2023-12-31) — Diluted EPS: 0.63
IRM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 184234000.00
IRM balance_sheet (annual, 2023-12-31) — Dividends Payable: 202392000.00
IRM income_statement (annual, 2023-12-31) — EBIT: 825609000.00
IRM income_statement (annual, 2023-12-31) — EBITDA: 1618627000.00
IRM cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -13885000.00
IRM cash_flow (annual, 2023-12-31) — End Cash Position: 222789000.00
IRM cash_flow (annual, 2023-12-31) — Financing Cash Flow: 425666000.00
IRM cash_flow (annual, 2023-12-31) — Free Cash Flow: -231530000.00
IRM cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 38000000.00
IRM cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -12825000.00
IRM income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 12825000.00
IRM income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -36799000.00
IRM balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -371156000.00
IRM income_statement (annual, 2023-12-31) — General And Administrative Expense: 873195000.00
IRM balance_sheet (annual, 2023-12-31) — Goodwill: 5017912000.00
IRM balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 6297678000.00
IRM balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 1334588000.00
IRM balance_sheet (annual, 2023-12-31) — Gross PPE: 13070013000.00
IRM income_statement (annual, 2023-12-31) — Gross Profit: 3122489000.00
IRM cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 89599000.00
IRM income_statement (annual, 2023-12-31) — Interest Expense: 598403000.00
IRM income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 598403000.00
IRM income_statement (annual, 2023-12-31) — Interest Income: 12471000.00
IRM income_statement (annual, 2023-12-31) — Interest Income Non Operating: 12471000.00
IRM cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 512446000.00
IRM balance_sheet (annual, 2023-12-31) — Interest Payable: 175218000.00
IRM balance_sheet (annual, 2023-12-31) — Invested Capital: 12144818000.00
IRM cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1444356000.00
IRM cash_flow (annual, 2023-12-31) — Issuance Of Debt: 19376168000.00
IRM balance_sheet (annual, 2023-12-31) — Land And Improvements: 536780000.00
IRM balance_sheet (annual, 2023-12-31) — Leases: 1166810000.00
IRM balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2562394000.00
IRM balance_sheet (annual, 2023-12-31) — Long Term Debt: 11812500000.00
IRM balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 14374894000.00
IRM cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 19376168000.00
IRM cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -18195776000.00
IRM balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1174332000.00
IRM balance_sheet (annual, 2023-12-31) — Minority Interest: 178072000.00
IRM income_statement (annual, 2023-12-31) — Minority Interests: -3029000.00
IRM cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -57679000.00
IRM balance_sheet (annual, 2023-12-31) — Net Debt: 11710381000.00
IRM cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 103134000.00
IRM income_statement (annual, 2023-12-31) — Net Income: 184234000.00
IRM income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 184234000.00
IRM income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 187263000.00
IRM income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 184234000.00
IRM income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 184234000.00
IRM cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 187263000.00
IRM income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 187263000.00
IRM cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -5874000.00